BioSpace News Archive

VoxNeuro Announces Significant Milestones as it Embarks on its Mission to Become “The Brain Company”.

Vertellus To Present Industry-Leading Portfolio of Medical Adhesives and Coatings at MD&M West 2022.

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced commercial availability of the company’s new solution for interventional rooms, Ambient Experience with FlexVision display, which will be showcased at the American College of Cardiology’s 71st Annual Scientific Session & Expo (ACC 2022), April 2-4, Washington, D.C., USA.

Revelation Biosciences Inc. announces results from interim statistical analysis for its Phase 2b viral challenge study (RVL-VRL01) to evaluate the efficacy of intranasal REVTx-99a.

The Cancer Registry of Norway is one of the oldest and most respected organisations of its kind in the world. It collects data and produces statistics of the cancer prevalence in Norway, has the administrative responsibility for the public screening programme in Norway and has an extensive research activity.

Contraline, Inc. has appointed medical device industry leader Dr. Yelena Tropsha to the role of Chief Technology Officer.

VivoSense, Inc. today announced the close of a $25 Million Series A financing round.

As per Precedence Research, the over the counter (OTC) drugs market size is estimated to hit US$ 294.18 billion by 2030 and growing at a CAGR of 6.9% from 2021 to 2030.

The pharmaceutical intermediates market is estimated to worth around US$ 47.1 billion by 2029 and growing at a CAGR of 6.3% from 2021 to 2030.

Precedence Research Predicts, the global oncology market size is expected to worth around US$ 536.01 billion by 2029 from valued at USD 286.04 billion in 2021 and growing at a CAGR of 8.2% from 2021 to 2030.